Industrial Biotechnology
Often referred to as 'white' biotech by the Europeans, industrial biotechnology represents the third wave of innovation in the biotech industry. It has applications in chemical industry, fermentation based products (yeast based products, organic Amino acids,
etc.), enzymes and green plastics.
Biodefense is yet another emerging field, involving development of technologies that can rapidly and efficiently transform garbagemainly plastic packaginginto fuel to generate electricity for troops in the battlefield or stationed in remote areas.
India Gaining Momentum
The market for industrial biotech products in India is growing at the rate of 6.38%, flourishing from a USD 52.22 million in 2002-03 to USD 55.56 million in 2003-04 (Source: ABLE-BioSpectrum Survey 2004). With the industry responding to a continuous stream
of innovative products, new applications have played a significant role in driving the demand. The Indian industrial biotechnology segment primarily consists of enzymes, organic amino acids and yeast products. Enzymes is the single largest market with revenues
close to USD 28.22 million and accounts for 56 % of the total domestic industrial biotech market.
Many Indian companies are active not just in the domestic market but also in the export market. Their products are being exported to many Asian and European countries. Companies such as Biocon, Rossari Biotech and Zytex (India) have received ISO certification
for their manufacturing facilities and processes reinstating that Indian companies are sensitive to quality and are making conscious efforts to meet the international standards. The Companies have been striving to produce different types of industrial enzymes,
using the natural methods of production, from plants and vegetable origin to fermentation and more.
Besides Biocon which has invested heavily in the R&D activity and developed innovative processes, most of the Indian companies have been largely focusing on the manufacturing part of the value chain. There is a tremendous scope for the industry to grow provided
more number of companies develop the expertise to innovate and implement high end technology based solutions/processes.
Gujarat potential to exploit the existing base
The market for industrial biotech products in India is growing at the rate of 6.38%, flourishing from a USD 52.22 million in 2002-03 to USD 55.56 million in 2003-04 (Source: ABLE-BioSpectrum Survey 2004). With the industry responding to a continuous stream
of innovative products, new applications have played a significant role in driving the demand. The Indian industrial biotechnology segment primarily consists of enzymes, organic amino acids and yeast products. Enzymes is the single largest market with revenues
close to USD 28.22 million and accounts for 56 % of the total domestic industrial biotech market.
Many Indian companies are active not just in the domestic market but also in the export market. Their products are being exported to many Asian and European countries. Companies such as Biocon, Rossari Biotech and Zytex (India) have received ISO certification
for their manufacturing facilities and processes reinstating that Indian companies are sensitive to quality and are making conscious efforts to meet the international standards. The Companies have been striving to produce different types of industrial enzymes,
using the natural methods of production, from plants and vegetable origin to fermentation and more.
Besides Biocon which has invested heavily in the R&D activity and developed innovative processes, most of the Indian companies have been largely focusing on the manufacturing part of the value chain. There is a tremendous scope for the industry to grow provided
more number of companies develop the expertise to innovate and implement high end technology based solutions/processes
